Tech Company Financing Transactions

BioAtla Funding Round

HBM Healthcare Investments, Soleus Capital and Boxer Capital joined a $72.5 million Series D funding round for BioAtla. The round was announced on 7/16/2020.

Transaction Overview

Company Name
Announced On
7/16/2020
Transaction Type
Venture Equity
Amount
$72,500,000
Round
Series D
Investors

HBM Healthcare Investments (Lead Investor)

Soleus Capital (Lead Investor)

Boxer Capital

Cormorant Asset Management

Farallon Capital Management

Janus Henderson Investors

Pappas Ventures

Pfizer Venture Investments

Proceeds Purpose
The company intends to use the funds to design, implement, and execute clinical programs evolving from its CAB platform that yields tumor-targeting antibodies with the potential for an enhanced benefit risk profile.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
11085 Torreyana Rd.
San Diego, CA 92121
USA
Email Address
Overview
BioAtla (Nasdaq: BCAB) is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms.
Profile
BioAtla LinkedIn Company Profile
Social Media
BioAtla Company Twitter Account
Company News
BioAtla News
Facebook
BioAtla on Facebook
YouTube
BioAtla on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jay Short
  Jay Short LinkedIn Profile  Jay Short Twitter Account  Jay Short News  Jay Short on Facebook
Chief Financial Officer
Richard Waldron
  Richard Waldron LinkedIn Profile  Richard Waldron Twitter Account  Richard Waldron News  Richard Waldron on Facebook
Chief Scientific Officer
Gerhard Frey
  Gerhard  Frey LinkedIn Profile  Gerhard  Frey Twitter Account  Gerhard  Frey News  Gerhard  Frey on Facebook
Co-Founder
Carolyn Short
  Carolyn Short LinkedIn Profile  Carolyn Short Twitter Account  Carolyn Short News  Carolyn Short on Facebook
Vice President
William Boyle
  William Boyle LinkedIn Profile  William Boyle Twitter Account  William Boyle News  William Boyle on Facebook
Vice President
Philippe Martin
  Philippe Martin LinkedIn Profile  Philippe Martin Twitter Account  Philippe Martin News  Philippe Martin on Facebook
Vice President
Monica Sullivan
  Monica Sullivan LinkedIn Profile  Monica Sullivan Twitter Account  Monica Sullivan News  Monica Sullivan on Facebook
VP - Bus. Development
Michael Melnick
  Michael Melnick LinkedIn Profile  Michael Melnick Twitter Account  Michael Melnick News  Michael Melnick on Facebook
VP - Human Resources
Susie Melody
  Susie Melody LinkedIn Profile  Susie Melody Twitter Account  Susie Melody News  Susie Melody on Facebook
VP - R & D
Cathy Chang
  Cathy Chang LinkedIn Profile  Cathy Chang Twitter Account  Cathy Chang News  Cathy Chang on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2020: Willful venture capital transaction
Next: 7/16/2020: Crisp venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary